CD8A and neoplasm: Overall, it is well established that tumour infiltrating CD8+ Tregs largely contribute to tumour immune escape and their levels correlate with cancer progression (Churlaud et al. 2015; Vieyra-Lobato et al. 2018; Yu et al. 2018).